Zai Lab to Present First Clinical Trial Data on ZL-1503
Zai Lab says data from the first clinical trial of its internally developed IL-13/IL-31Rα bispecific antibody will be shared for the first time at the American College of Allergy, Asth…
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Zai Lab to Present Data From First Clinical Trial Evaluating ZL — 1503, an IL — 13/IL — 31Rα Bispecific Antibody, for Atopic Diseases
For best results when printing this announcement, please click on link below: Zai Lab to Present Data From First Clinical Trial Evaluating ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, for Atopic Diseases - Findings from healthy volunteers in the Phase 1/1b trial will be shared at ACAAI 2026 Annual Scientific Meeting